Condition
Fibrillary Glomerulonephritis clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Fibrillary Glomerulonephritis clinical trials that are recruiting, at sites in 2 countries (most in United States (1), United Kingdom (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Using Obinutuzumab to treat Fibrillary Glomerulonephritis
This study is testing if the drug Obinutuzumab can help adults with fibrillary glomerulonephritis improve their kidney function and slow down the disease.
-
National Registry for Rare Kidney Diseases
This study is collecting health information from people with rare kidney diseases to help improve treatments and create better care guidelines.
Related topics
Quick answers
How many Fibrillary Glomerulonephritis clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.